First Time Loading...
P

Pear Therapeutics Inc
NASDAQ:PEAR

Watchlist Manager
Pear Therapeutics Inc
NASDAQ:PEAR
Watchlist
Price: 0.0077 USD -15.38% Market Closed
Updated: May 7, 2024

Pear Therapeutics Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pear Therapeutics Inc
Revenue Peer Comparison

Comparables:
VEEV
INSP
EVH
DOCS
GDRX

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
P
Pear Therapeutics Inc
NASDAQ:PEAR
Revenue
$12.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Revenue
$2.4B
CAGR 3-Years
17%
CAGR 5-Years
22%
CAGR 10-Years
27%
Inspire Medical Systems Inc
NYSE:INSP
Revenue
$624.8m
CAGR 3-Years
76%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Evolent Health Inc
NYSE:EVH
Revenue
$2B
CAGR 3-Years
29%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Revenue
$419.1m
CAGR 3-Years
53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Goodrx Holdings Inc
NASDAQ:GDRX
Revenue
$750.3m
CAGR 3-Years
11%
CAGR 5-Years
25%
CAGR 10-Years
N/A

See Also

What is Pear Therapeutics Inc's Revenue?
Revenue
12.7m USD

Based on the financial report for Dec 31, 2022, Pear Therapeutics Inc's Revenue amounts to 12.7m USD.

What is Pear Therapeutics Inc's Revenue growth rate?
Revenue CAGR 1Y
202%

Over the last year, the Revenue growth was 202%.